RAI1 Gene 17P11.2 Deletion+Duplication

Clinical trial pipeline · Data from ClinicalTrials.gov

See which RAI1 Gene 17P11.2 Deletion+Duplication trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06274164

Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders

Currently, there is no clinically available genetic-based treatment for RAI1 (Retinoic Acid-Induced 1) -related disorders other than symptomatic management and…

United States90 participantsStarted 2024-03-13

Treatment: Electroencephalography/Polysomnography (EEG/PSG), Skin Biopsy

RAI1 Gene 17P11.2 Deletion+Duplication

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders

All recent trials (1 shown)